Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1267 |
|---|---|
| Identifier | NCT05299931 |
| Trial Title | An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ustekinumab |
Participant Information
| Sponsor | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW |
|---|---|
| City | Zaventem |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-09-10 |
|---|---|
| Primary Completion Date | 2026-06 |
| Completion Date | 2026-06 |